Literature DB >> 11199812

Parkinson's disease and sleep.

P Clarenbach1.   

Abstract

There are many reasons for patients with idiopathic Parkinson's disease to develop sleep disorders and subsequent daytime sleepiness. Important causes are reduction of total sleep duration and sleep efficiency, and an increase in respiratory and motor arousals. This daytime sleepiness at first glance seems different from the "sleep attacks" which caused motot vehicle mishaps reported recently in persons taking pramipexole and ropinirole. There is, however, only little evidence that we deal with a new phenomenon in a new clinical situation, i. e. cataplexy-like attacks after high doses of new non-ergot dopamine-agonists. Until now there is no single case of a proven cataplexy on one hand, and older dopamine agonists like pergolide as well as L-Dopa + carbidopa have been reported to induce sudden onsets of sleep, too.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11199812     DOI: 10.1007/pl00022915

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  3 in total

1.  Effect of exogenous melatonin on sleep and motor dysfunction in Parkinson's disease. A randomized, double blind, placebo-controlled study.

Authors:  Camila Andrade Mendes Medeiros; Pedro Felipe Carvalhedo de Bruin; Lívia Ariane Lopes; Maria Cecília Magalhães; Maria de Lourdes Seabra; Veralice Meireles Sales de Bruin
Journal:  J Neurol       Date:  2007-04-03       Impact factor: 4.849

Review 2.  Sleep attacks in patients taking dopamine agonists: review.

Authors:  Carl Nikolaus Homann; Karoline Wenzel; Klaudia Suppan; Gerd Ivanic; Norbert Kriechbaum; Richard Crevenna; Erwin Ott
Journal:  BMJ       Date:  2002-06-22

3.  Cul3 and the BTB adaptor insomniac are key regulators of sleep homeostasis and a dopamine arousal pathway in Drosophila.

Authors:  Cory Pfeiffenberger; Ravi Allada
Journal:  PLoS Genet       Date:  2012-10-04       Impact factor: 5.917

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.